Dr. James Luketich, University of Pittsburgh Medical Center and University of Pittsburgh Physicians have settled with the United States government over a whistleblower lawsuit, brought in September 2021, that alleged fraudulent billing and unsafe surgical practices.
Mohamad Takwa, CEO of Epigenica, an epigenetic-profiling company based in Sweden talks about the technology and its opportunities for healthcare, including the creation of epigenetic drugs.
Interoperability Institute EVP Mary Kratz previews the her HIMSS23 panel on the power of open-source solutions and cross-sector challenges to achieving interoperability.
J. Tod Fetherling, managing director at Huron, previews his HIMSS23 discussion on models panelists developed that can help in lung cancer detection and translating analytics into patient communication.
It’s been a big week for telehealth. What’s new in the world of virtual care? We’ll go over the latest in this week’s Top Stories, including the AHA’s support of bipartisan telehealth legislation, and results of a telemedicine-focused Rock Health study. For more news and features from Jeff Lagasse visit Healthcare Finance News. In this […]
Avaneer Health, the digital network founded by Aetna, Elevance Health, the Cleveland Clinic; Health Care Service Corporation, Sentara Healthcare and others, has announced a peer-to-peer care delivery system between payers, providers and other participants.
SVP of healthcare delivery innovation at Thomas Jefferson University Judd Hollander, highlights his upcoming HIMSS23 session explaining how provider organizations must transform virtual care from an enabler of strategy to a strategy of its own.
The House Oversight Committee has launched an investigation into pharmacy benefit managers’ tactics that Chairman James Comer (R-KY) said are “harming patient care and increasing costs for consumers.”
Payers saw their Medicare Advantage margins revert back to pre-pandemic levels in 2021, yet those margins were still double those seen in other markets, according to a new analysis from the Kaiser Family Foundation. By the end of 2021, gross margins per enrollee had returned to pre-pandemic levels in the Medicare Advantage market, while gross […]
Eli Lilly has announced that it is reducing the list price of its insulin by 70% and capping out-of-pocket costs at $35 a month as part of its Insulin Value Program.